Application 021335

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLEEVECIMATINIB MESYLATECAPSULE;ORALEQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002GLEEVECIMATINIB MESYLATECAPSULE;ORALEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
42106SUPPL2004-09-29
21606SUPPL2004-08-09
5067SUPPL2004-06-04
44117ORIG2003-12-09
5068SUPPL2003-11-25
27505SUPPL2003-07-23
42105SUPPL2003-07-08
21605SUPPL2003-07-08
36678SUPPL2003-05-20
36677SUPPL2003-04-09
36679SUPPL2002-12-20
36676SUPPL2002-02-01
27504SUPPL2002-02-01
21604ORIG2001-05-10
15209ORIG2001-05-10
5066ORIG2001-05-10